Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-11-17 1:18:54 pm | Protalix BioTherapeutics: Fiscal Challenges And Gout Therapy Prospects | SeekingAlpha |
| 2023-11-07 6:4:47 am | Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call Transcript | Insider Monkey |
| 2023-11-07 1:25:0 am | PLX: More Regulatory Approvals | Zacks Small Cap Research |
| 2023-11-06 5:4:29 am | Protalix BioTherapeutics Inc (PLX) Reports Q3 2023 Financial Results | GuruFocus.com |
| 2023-11-06 3:58:32 am | Protalix: Q3 Earnings Snapshot | Associated Press Finance |
| 2023-11-06 3:50:0 am | Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results | PR Newswire |
| 2023-10-30 3:50:0 am | Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023 | PR Newswire |
| 2023-10-09 3:50:0 am | Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel | PR Newswire |
| 2023-09-12 3:50:0 am | Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors | PR Newswire |
Please consider a small donation if you think this website provides you with relevant information